🔗 Permalink

Inventor profile of:

Samuel Strober

City:

Stanford, California

Country:

United States

Published Applications:

Last publication date:

2023-08-10

Top Assignees for applications by Samuel Strober

The entities that hold a legal rights for patent applications filed by inventor Strober Samuel:

The Board of Trustees of the Leland Stanford Junior University 33 Stanford, CA United States
The Board of Trustees of the Leland Stanford Junior University 3 Palo Alto, CA United States

Recent patent applications by Strober Samuel

Samuel Strober from Stanford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-08-10

US20230248812A1

Human necessities

TUMOR VACCINATION IN COMBINATION WITH HEMATOPOIETIC CELL TRANSPLANTATION FOR CANCER THERAPY

#2 | 2023-04-13

US20230113240A1

Human necessities

METHODS FOR CANCER TREATMENT

#3 | 2022-11-17

US20220362291A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#4 | 2022-01-13

US20220008468A1

Human necessities

ANTI-TUMOR T CELL IMMUNITY INDUCED BY HIGH DOSE RADIATION

#5 | 2021-07-01

US20210196754A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#6 | 2020-08-13

US20200254015A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts

#7 | 2020-05-28

US20200164195A1

Human necessities

Methods for cancer treatment

#8 | 2019-11-28

US20190358257A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#9 | 2019-11-07

US20190336528A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#10 | 2019-10-03

US20190298762A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#11 | 2019-07-04

US20190201514A1

Human necessities

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

#12 | 2019-06-27

US20190192562A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#13 | 2019-06-27

US20190192561A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#14 | 2019-03-28

US20190091262A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#15 | 2019-03-21

US20190083537A1

Human necessities

Anti-tumor T cell immunity induced by high dose radiation

#16 | 2019-03-21

US20190083530A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#17 | 2019-01-03

US20190000877A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts

#18 | 2018-12-06

US20180344766A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#19 | 2018-08-30

US20180243337A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#20 | 2018-08-09

US20180221410A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#21 | 2018-08-09

US20180221409A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#22 | 2018-07-12

US20180193380A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#23 | 2018-07-12

US20180193379A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#24 | 2017-05-04

US20170119821A1

Human necessities

Anti-tumor T cell immunity induced by high dose radiation

#25 | 2017-05-04

US20170119819A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#26 | 2017-04-20

US20170106086A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts

#27 | 2017-01-19

US20170014453A1

Human necessities

Enhancement of allogeneic hematopoietic stem cell transplantation

#28 | 2016-12-29

US20160376653A1

Chemistry; metallurgy

Biomarkers for determining an allograft tolerant phenotype

#29 | 2016-03-03

US20160058993A1

Human necessities

Methods for cancer treatment

#30 | 2016-02-25

US20160051653A1

Human necessities

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

#31 | 2015-12-24

US20150366964A1

Human necessities

Anti-tumor T cell immunity induced by high dose radiation

#32 | 2015-10-01

US20150272993A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of grafts

#33 | 2015-08-06

US20150216900A1

Human necessities

Enhancement of allogeneic hematopoietic stem cell transplantation

#34 | 2014-08-28

US20140243577A1

Human necessities

Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts

#35 | 2014-08-28

US20140242118A1

Human necessities

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

#36 | 2014-03-13

US20140073832A1

Human necessities

Anti-tumor T cell immunity induced by high dose radiation

#37 | 2012-12-27

US20120329668A1

Chemistry; metallurgy

Biomarkers for determining an allograft tolerant phenotype

#38 | 2012-07-12

US20120177621A1

Human necessities

Enhancement of Allogeneic Hematopoietic Stem Cell Transplantation

#39 | 2010-08-05

US20100197613A1

Human necessities

Methods for relieving asthma-associated airway hyperresponsiveness

#40 | 2006-06-01

US20060116332A1

Human necessities

Methods for inhibition of NKT cells

InventorID:

687466 ⎘